HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Gene Signatures and Prognostic Values of m6A RNA Methylation Regulators in Ovarian Cancer.

AbstractBACKGROUND:
N6-methyladenosine (m6A) is the most common form of mRNA modification under the field of "RNA epigenetics." However, its role in ovarian cancer (OC) development is poorly understood. In the current study, we aimed to identify gene signatures and prognostic values of m6A RNA methylation regulators.
METHOD:
Specifically, we downloaded Mutations and Copy number variant (CNV) data from the TCGA database for 579 OC patients, then analyzed gene expression and prognosis value using integrative bioinformatics. Thereafter, we verified the related biological processes of Wilms' tumor 1-associating protein (WTAP) gene using Gene set enrichment analysis (GSEA).
RESULTS:
Results showed that almost all ovarian cancer patients (99.31%) have CNVs with at least 1 m6A regulatory gene, whereas 83.76% of cases exhibited concurrence of CNVs in more than 4 m6A regulatory genes. Additionally, alteration of m6A regulators was associated with historical grade, whereas integrative bioinformatics and Cox multivariate model analysis revealed a significant correlation between high WTAP expression and worse ovarian cancer outcomes. Moreover, GSEA revealed that high WTAP expression was associated with cell cycle regulation and MYC targets.
CONCLUSION:
Overall, our findings demonstrate the significance of high-frequency genetic alterations of m6A RNA methylation regulators and WTAP's poor prognosis value in OC. These findings provide valuable insights into the role of m6A methylation in OC, and will be vital in guiding development of novel treatment therapies.
AuthorsXiao Han, Jie Liu, Guomei Cheng, Shihong Cui
JournalCancer control : journal of the Moffitt Cancer Center (Cancer Control) 2020 Jan-Dec Vol. 27 Issue 1 Pg. 1073274820960460 ISSN: 1526-2359 [Electronic] United States
PMID32951457 (Publication Type: Journal Article)
Chemical References
  • Biomarkers, Tumor
  • Cell Cycle Proteins
  • RNA Splicing Factors
  • WTAP protein, human
  • N-methyladenosine
  • Adenosine
Topics
  • Adenosine (analogs & derivatives, chemistry)
  • Biomarkers, Tumor (genetics)
  • Cell Cycle Proteins (genetics)
  • DNA Methylation
  • Female
  • Follow-Up Studies
  • Gene Expression Profiling
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Middle Aged
  • Ovarian Neoplasms (genetics, pathology)
  • Prognosis
  • RNA Splicing Factors (genetics)
  • Retrospective Studies
  • Survival Rate

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: